English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51925520    Online Users :  896
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"jen chang ko"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 121-170 of 290  (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-03-11T08:34:21Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; Min-Shu Hsieh; MENG-RUI LEE; LI-TA KENG; JEN-CHANG KO; Jin-Yuan Shih
臺大學術典藏 2021-03-11T08:34:21Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; Min-Shu Hsieh; MENG-RUI LEE; LI-TA KENG; JEN-CHANG KO; Jin-Yuan Shih
臺大學術典藏 2021-03-11T08:34:21Z Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression Jen-Chang Ko;Zheng H.-Y.;Chen W.-C.;Peng Y.-S.;Wu C.-H.;Wei C.-L.;Chen J.-C.;Lin Y.-W.; JEN-CHANG KO; Zheng H.-Y.; Chen W.-C.; Peng Y.-S.; Wu C.-H.; Wei C.-L.; Chen J.-C.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:21Z Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression Jen-Chang Ko;Zheng H.-Y.;Chen W.-C.;Peng Y.-S.;Wu C.-H.;Wei C.-L.;Chen J.-C.;Lin Y.-W.; JEN-CHANG KO; Zheng H.-Y.; Chen W.-C.; Peng Y.-S.; Wu C.-H.; Wei C.-L.; Chen J.-C.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:20Z Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan Lee M.-R.;Ho C.-M.;Lee C.-H.;Lee M.-C.;Chang L.-Y.;Yu K.-L.;Jen-Chang Ko;Wang J.-Y.;Wang J.-T.;Lee L.-N.; MENG-RUI LEE; Cheng-Maw Ho; Chih-Hsin Lee; Ming-Chia Lee; LIH-YU CHANG; KAI-LUN YU; JEN-CHANG KO; Jann-Yuan Wang; Jann-Tay Wang; Li-Na Lee
臺大學術典藏 2021-03-11T08:34:20Z Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan Lee M.-R.;Ho C.-M.;Lee C.-H.;Lee M.-C.;Chang L.-Y.;Yu K.-L.;Jen-Chang Ko;Wang J.-Y.;Wang J.-T.;Lee L.-N.; MENG-RUI LEE; Cheng-Maw Ho; Chih-Hsin Lee; Ming-Chia Lee; LIH-YU CHANG; KAI-LUN YU; JEN-CHANG KO; Jann-Yuan Wang; Jann-Tay Wang; Li-Na Lee
臺大學術典藏 2021-03-11T08:34:20Z Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in Taiwan Chang C.-H.;Lee C.-H.;Jen-Chang Ko;Chang L.-Y.;Lee M.-C.;Wang J.-Y.;Yu C.-J.; CHIA-HAO CHANG; Chih-Hsin Lee; JEN-CHANG KO; LIH-YU CHANG; Ming-Chia Lee; Jann-Yuan Wang; Chong-Jen Yu
臺大學術典藏 2021-03-11T08:34:20Z Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in Taiwan Chang C.-H.;Lee C.-H.;Jen-Chang Ko;Chang L.-Y.;Lee M.-C.;Wang J.-Y.;Yu C.-J.; CHIA-HAO CHANG; Chih-Hsin Lee; JEN-CHANG KO; LIH-YU CHANG; Ming-Chia Lee; Jann-Yuan Wang; Chong-Jen Yu
臺大學術典藏 2021-03-11T08:34:20Z Cementing an unwanted relationship Chang C.-H.;Keng L.-T.;Jen-Chang Ko; CHIA-HAO CHANG; LI-TA KENG; JEN-CHANG KO
臺大學術典藏 2021-03-11T08:34:20Z Cementing an unwanted relationship Chang C.-H.;Keng L.-T.;Jen-Chang Ko; CHIA-HAO CHANG; LI-TA KENG; JEN-CHANG KO
臺大學術典藏 2021-03-11T08:34:19Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏 2021-03-11T08:34:19Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏 2021-03-11T08:34:19Z Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study Liao Y.-C.;Liao W.-Y.;Sun J.-L.;Jen-Chang Ko;Yu C.-J.; Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Chong-Jen Yu
臺大學術典藏 2021-03-11T08:34:19Z Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study Liao Y.-C.;Liao W.-Y.;Sun J.-L.;Jen-Chang Ko;Yu C.-J.; Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Chong-Jen Yu
臺大學術典藏 2021-03-11T08:34:19Z Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study Wei Y.-F.;Huang W.-T.;Liu T.-C.;Shieh J.-M.;Chian C.-F.;Wu M.-F.;Chang C.-C.;Lin C.-H.;Jen-Chang Ko;Lin C.-M.;Hsia T.-C.; Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C.
臺大學術典藏 2021-03-11T08:34:19Z Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study Wei Y.-F.;Huang W.-T.;Liu T.-C.;Shieh J.-M.;Chian C.-F.;Wu M.-F.;Chang C.-C.;Lin C.-H.;Jen-Chang Ko;Lin C.-M.;Hsia T.-C.; Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C.
臺大學術典藏 2021-03-11T08:34:18Z Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations Liang S.-K.;Jen-Chang Ko;Yang J.C.-H.;Shih J.-Y.; SHENG-KAI LIANG; JEN-CHANG KO; James Chih-Hsin Yang; Jin-Yuan Shih
臺大學術典藏 2021-03-11T08:34:18Z Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations Liang S.-K.;Jen-Chang Ko;Yang J.C.-H.;Shih J.-Y.; SHENG-KAI LIANG; JEN-CHANG KO; James Chih-Hsin Yang; Jin-Yuan Shih
臺大學術典藏 2021-03-11T08:34:18Z Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells Jen-Chang Ko;Chen J.-C.;Chen T.-Y.;Yen T.-C.;Ma P.-F.;Lin Y.-C.;Wu C.-H.;Peng Y.-S.;Zheng H.-Y.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Chen T.-Y.; Yen T.-C.; Ma P.-F.; Lin Y.-C.; Wu C.-H.; Peng Y.-S.; Zheng H.-Y.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:18Z Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells Jen-Chang Ko;Chen J.-C.;Chen T.-Y.;Yen T.-C.;Ma P.-F.;Lin Y.-C.;Wu C.-H.;Peng Y.-S.;Zheng H.-Y.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Chen T.-Y.; Yen T.-C.; Ma P.-F.; Lin Y.-C.; Wu C.-H.; Peng Y.-S.; Zheng H.-Y.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:18Z Capsaicin enhances erlotinib-induced cytotoxicity: Via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells Chen J.-C.;Jen-Chang Ko;Yen T.-C.;Chen T.-Y.;Lin Y.-C.;Ma P.-F.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Yen T.-C.; Chen T.-Y.; Lin Y.-C.; Ma P.-F.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:18Z Capsaicin enhances erlotinib-induced cytotoxicity: Via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells Chen J.-C.;Jen-Chang Ko;Yen T.-C.;Chen T.-Y.;Lin Y.-C.;Ma P.-F.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Yen T.-C.; Chen T.-Y.; Lin Y.-C.; Ma P.-F.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:17Z Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study Lee M.-R.;Lee C.-H.;Wang J.-Y.;Lee S.-W.;Jen-Chang Ko;Lee L.-N.; Meng-Rui Lee; Lee C.-H.; Wang J.-Y.; Lee S.-W.; JEN-CHANG KO; Lee L.-N.
臺大學術典藏 2021-03-11T08:34:17Z Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study Lee M.-R.;Lee C.-H.;Wang J.-Y.;Lee S.-W.;Jen-Chang Ko;Lee L.-N.; Meng-Rui Lee; Lee C.-H.; Wang J.-Y.; Lee S.-W.; JEN-CHANG KO; Lee L.-N.
臺大學術典藏 2021-03-11T08:34:17Z Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study Lee M.-R.;Yu K.-L.;Kuo H.-Y.;Liu T.-H.;Jen-Chang Ko;Tsai J.-S.;Wang J.-Y.; MENG-RUI LEE; KAI-LUN YU; HUNG-YANG KUO; Tsung-Hao Liu; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y.
臺大學術典藏 2021-03-11T08:34:17Z Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study Lee M.-R.;Yu K.-L.;Kuo H.-Y.;Liu T.-H.;Jen-Chang Ko;Tsai J.-S.;Wang J.-Y.; MENG-RUI LEE; KAI-LUN YU; HUNG-YANG KUO; Tsung-Hao Liu; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y.
臺大學術典藏 2021-03-11T08:34:17Z Downregulation of xeroderma pigmentosum complementation group c expression by 17-allylamino-17-demethoxygeldanamycin enhances bevacizumab-induced cytotoxicity in human lung cancer cells Chen J.-C.;Jen-Chang Ko;Taso Y.-C.;Cheng H.-H.;Chen T.-Y.;Yen T.-C.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Taso Y.-C.; Cheng H.-H.; Chen T.-Y.; Yen T.-C.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:17Z Downregulation of xeroderma pigmentosum complementation group c expression by 17-allylamino-17-demethoxygeldanamycin enhances bevacizumab-induced cytotoxicity in human lung cancer cells Chen J.-C.;Jen-Chang Ko;Taso Y.-C.;Cheng H.-H.;Chen T.-Y.;Yen T.-C.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Taso Y.-C.; Cheng H.-H.; Chen T.-Y.; Yen T.-C.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:16Z Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study Lee M.-R.;Huang H.-L.;Chen L.-C.;Yang H.-C.;Jen-Chang Ko;Cheng M.-H.;Chong I.-W.;Lee L.-N.;Wang J.-Y.;Dimopoulos G.; MENG-RUI LEE; Huang H.-L.; Lun-Che Chen; HAN-CHING YANG; JEN-CHANG KO; Cheng M.-H.; Chong I.-W.; Lee L.-N.; Wang J.-Y.; Dimopoulos G.
臺大學術典藏 2021-03-11T08:34:16Z Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study Lee M.-R.;Huang H.-L.;Chen L.-C.;Yang H.-C.;Jen-Chang Ko;Cheng M.-H.;Chong I.-W.;Lee L.-N.;Wang J.-Y.;Dimopoulos G.; MENG-RUI LEE; Huang H.-L.; Lun-Che Chen; HAN-CHING YANG; JEN-CHANG KO; Cheng M.-H.; Chong I.-W.; Lee L.-N.; Wang J.-Y.; Dimopoulos G.
臺大學術典藏 2021-03-11T08:34:16Z Nontuberculous mycobacterial lung disease epidemiology in Taiwan: A systematic review Lee M.-R.;Chang L.-Y.;Jen-Chang Ko;Wang H.-C.;Huang Y.-W.; MENG-RUI LEE; LIH-YU CHANG; JEN-CHANG KO; Wang H.-C.; Huang Y.-W.
臺大學術典藏 2021-03-11T08:34:16Z Nontuberculous mycobacterial lung disease epidemiology in Taiwan: A systematic review Lee M.-R.;Chang L.-Y.;Jen-Chang Ko;Wang H.-C.;Huang Y.-W.; MENG-RUI LEE; LIH-YU CHANG; JEN-CHANG KO; Wang H.-C.; Huang Y.-W.
臺大學術典藏 2021-03-11T08:34:16Z Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer Cells Jen-Chang Ko;Chen J.-C.;Yen T.-C.;Chen T.-Y.;Ma P.-F.;Lin Y.-C.;Cheng H.-H.;Taso Y.-C.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Yen T.-C.; Chen T.-Y.; Ma P.-F.; Lin Y.-C.; Cheng H.-H.; Taso Y.-C.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:16Z Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer Cells Jen-Chang Ko;Chen J.-C.;Yen T.-C.;Chen T.-Y.;Ma P.-F.;Lin Y.-C.;Cheng H.-H.;Taso Y.-C.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Yen T.-C.; Chen T.-Y.; Ma P.-F.; Lin Y.-C.; Cheng H.-H.; Taso Y.-C.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:15Z Cross-talk between SOX2 and TGFb signaling regulates EGFR-TKI tolerance and lung cancer dissemination Kuo M.-H.; Lee A.-C.; Hsiao S.-H.; Lin S.-E.; Chiu Y.-F.; Yang L.-H.; Yu C.-C.; Chiou S.-H.; Huang H.-N.; JEN-CHANG KO; Chou Y.-T.
臺大學術典藏 2021-03-11T08:34:15Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Wen Y.-F.; MENG-RUI LEE; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-03-11T08:34:15Z Effect of β-Blocker in Treatment-Naive Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs Chang C.-H.;Lee C.-H.;Jen-Chang Ko;Chang L.-Y.;Lee M.-C.;Zhang J.-F.;Wang J.-Y.;Shih J.-Y.;Yu C.-J.; CHIA-HAO CHANG; Lee C.-H.; JEN-CHANG KO; LIH-YU CHANG; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-03-11T08:34:15Z Effect of β-Blocker in Treatment-Naive Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs Chang C.-H.;Lee C.-H.;Jen-Chang Ko;Chang L.-Y.;Lee M.-C.;Zhang J.-F.;Wang J.-Y.;Shih J.-Y.;Yu C.-J.; CHIA-HAO CHANG; Lee C.-H.; JEN-CHANG KO; LIH-YU CHANG; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-03-11T08:34:14Z Capsaicin Acts Through Reducing P38 MAPK-Dependent Thymidylate Synthase Expression to Enhance 5-Fluorouracil-Induced Cytotoxicity in Human Lung Cancer Cells Tung C.-L.; Chen J.-C.; JEN-CHANG KO; Liu L.-L.; Chien C.-C.; Huang I.-H.; Tsao Y.-C.; Cheng H.-H.; Chen T.-Y.; Yen T.-C.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:29:45Z Lobar bronchioloalveolar carcinoma: an ultrasound study. JEN-CHANG KO; Yang P.C.; Luh K.T.; Kuo S.H.; Chang D.B.; Yu C.J.
臺大學術典藏 2021-03-11T08:29:45Z Superior vena cava syndrome: Rapid histologic diagnosis by ultrasound- guided transthoracic needle aspiration biopsy JEN-CHANG KO; Yang P.-C.; Yuan A.; Chang D.-B.; Yu C.-J.; Wu H.-D.; Lee L.-N.; Kuo S.-H.; Luh K.-T.
臺大學術典藏 2021-03-11T08:29:44Z Panhypopituitarism caused by solitary parasellar metastasis from lung cancer JEN-CHANG KO; Yang P.-C.; Huang T.-S.; Yeh K.-H.; Kuo S.-H.; Luh K.T.
臺大學術典藏 2021-03-11T08:29:44Z Ultrasonographic evaluation of peridiaphragmatic lesions: A prospective study JEN-CHANG KO; Yang P.-C.; Chang D.-B.; Yu C.-J.; Lee L.-N.; Kuo S.-H.; Luh K.-T.
臺大學術典藏 2021-03-11T08:29:44Z Ultrasound guided pericardial drainage and intrapericardial instillation of mitomycin C for malignant pericardial effusion Lee L.-N.; Luh K.-T.; Yang P.-C.; Chang D.-B.; Yu C.-J.; JEN-CHANG KO; Liaw Y.-S.; Wu R.-G.
臺大學術典藏 2021-03-11T08:29:43Z Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells Jen-Chang Ko;Ciou S.-C.;Cheng C.-M.;Wang L.-H.;Hong J.-H.;Jheng M.-Y.;Ling S.-T.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:29:43Z Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells Jen-Chang Ko;Ciou S.-C.;Cheng C.-M.;Wang L.-H.;Hong J.-H.;Jheng M.-Y.;Ling S.-T.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:29:43Z Disseminated coccidioidomycosis [8] Wang C.-Y.;Jerng J.-S.;Jen-Chang Ko;Lin M.-F.;Hsiao C.-H.;Lee L.-N.;Hsueh P.-R.;Kuo S.-H.; Wang C.-Y.; Jerng J.-S.; JEN-CHANG KO; Lin M.-F.; Hsiao C.-H.; Lee L.-N.; Hsueh P.-R.; Kuo S.-H.
臺大學術典藏 2021-03-11T08:29:43Z Disseminated coccidioidomycosis [8] Wang C.-Y.;Jerng J.-S.;Jen-Chang Ko;Lin M.-F.;Hsiao C.-H.;Lee L.-N.;Hsueh P.-R.;Kuo S.-H.; Wang C.-Y.; Jerng J.-S.; JEN-CHANG KO; Lin M.-F.; Hsiao C.-H.; Lee L.-N.; Hsueh P.-R.; Kuo S.-H.
臺大學術典藏 2021-03-11T08:29:43Z Dual and opposing roles of ERK in regulating G1 and S-G 2/M delays in A549 cells caused by hyperoxia Jen-Chang Ko;Wang Y.-T.;Yang J.-L.; JEN-CHANG KO; Wang Y.-T.; Yang J.-L.
臺大學術典藏 2021-03-11T08:29:43Z Dual and opposing roles of ERK in regulating G1 and S-G 2/M delays in A549 cells caused by hyperoxia Jen-Chang Ko;Wang Y.-T.;Yang J.-L.; JEN-CHANG KO; Wang Y.-T.; Yang J.-L.

Showing items 121-170 of 290  (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page